E-papers
E-Paper-Ausgaben sind exakte digitale Kopien der DTI-Printpublikationen. Leser können das E-Paper durchsuchen und darin navigieren sowie Seiten herunterladen und ausdrucken, um sie offline zu lesen. Um eine weite Verbreitung bei unserer internationalen Leserschaft zu fördern, ist der Zugang zu den meisten E-Papern kostenlos.
:sharpen(level=0):output(format=jpeg)/up/dt/e-papers/312669/1.jpg)
today EAO Annual Scientific Meeting Geneva Sept. 29–Oct. 1, 2022
EAO congress makes comeback in novel hybrid format / BioHorizons Camlog organises comprehensive educational programme for EAO 2022 congress attendees / “We are planning to make quite an impact at the EAO congress” / First hybrid edition of EAO congress is critically evaluating technological developments in dentistry / News / Interview: “Innovation in education and enablement is a continuous journey” / Interview: CleanImplant Foundation: Greater safety in implantology and a stage for quality manufacturers / Interview: “Clinicians buy too many products and cannot necessarily make use of all of them” / News / Interview: “At Neoss, we have the luxury of being able to be more forward-oriented” / News / Industry / Floor plan / Exhibitors / Travel /
- EAO congress makes comeback in novel hybrid format 1 - 1
- BioHorizons Camlog organises comprehensive educational programme for EAO 2022 congress attendees 1 - 2
- “We are planning to make quite an impact at the EAO congress” 1 - 2
- First hybrid edition of EAO congress is critically evaluating technological developments in dentistry 4 - 4
- News 6 - 6
- Interview: “Innovation in education and enablement is a continuous journey” 8 - 8
- Interview: CleanImplant Foundation: Greater safety in implantology and a stage for quality manufacturers 10 - 10
- Interview: “Clinicians buy too many products and cannot necessarily make use of all of them” 12 - 12
- News 13 - 15
- Interview: “At Neoss, we have the luxury of being able to be more forward-oriented” 16 - 16
- News 18 - 20
- Industry 22 - 27
- Floor plan 28 - 28
- Exhibitors 29 - 29
- Travel 30 - 30